Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
Clinical trial NCT06563375 · RECRUITING
Trial details
- NCT number
- NCT06563375
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-05
- Primary completion
- 2028-09-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.